Please try another search
Prostatype Genomics AB manufactures, markets, and sells the prognostic gene tests. It offers Prostatype Test System that combines gene expression information with used clinical parameters, such as PSA, Gleason Score, and Tumor Stage, as well as calculates the P-score. The company’s test is based on database containing prostate cancer patients, as well as provides decision support for patients and doctors when making a treatment decision. Prostatype Genomics AB (publ) was incorporated in 2007 and is based in Solna, Sweden.
Name | Age | Since | Title |
---|---|---|---|
Anders Lundberg | - | 2017 | Independent Chairman of the Board |
Hakan Englund | 71 | 2019 | Independent Director |
Michael Haggman | - | 2018 | Independent Director |
Rolf Skoglund | - | - | Member of Advisory Board |
Mattias Prage | - | 2022 | Independent Director |
Jörgen Dahlström | - | 2023 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review